In a study of the role of Mettl3 in age-related neurodegenerative diseases, Mettl3 levels were reduced in the brains of patients with mild cognitive impairment, which is the prodromal phase of AD, as well as in AD patients (Zhang et al., 2018; Huang et al., 2020). Here, METTL3 is linked to Alzheimer disease.